Content about J.P. Morgan

February 13, 2013
Harris Teeter may be next grocer to explore 'strategic options'

Carolina retailer Harris Teeter may be exploring a sale, the Wall Street Journal reported Tuesday evening.

MATTHEWS, N.C. — Carolina retailer Harris Teeter may be exploring a sale, the Wall Street Journal reported Tuesday evening. 

According to the report, Harris Teeter is being advised by JP Morgan. WSJ tabulated Harris Teeter's market value at $1.8 billion for its 200 supermarkets. 

December 21, 2012
Watson to present at Goldman Sachs, J.P. Morgan healthcare conferences

Watson Pharmaceuticals will present at two conferences sponsored by financial banks, the company said.

PARSIPPANY, N.J. — Watson Pharmaceuticals will present at two conferences sponsored by financial banks, the company said.

Watson said that president and CEO Paul Bisaro would provide an overview and update of the company's business at the 2013 Goldman Sachs "Healthcare CEOs Unscripted: A View from the Top" conference, scheduled for Jan. 3, 2013, at the Goldman Sachs Conference Center in New York.

Six days later, on Jan. 9, Bisaro will present at the annual J.P. Morgan Healthcare Conference, at the Westin St. Francis Hotel in San Francisco.

June 29, 2012
Coty eyes up to $700M in IPO

Coty has filed to raise as much as $700 million in an initial public offering.

NEW YORK — Coty has filed to raise as much as $700 million in an initial public offering. The filing with the Securities and Exchange Commission comes about a month after the beauty company dropped its bid for Avon because of Avon’s “delay and unwillingness to engage in discussions.”

In the filing, Coty told the SEC that it intends to list the Class A common stock on either the NASDAQ or the New York Stock Exchange under the symbol “COTY.” Coty did not reveal how many shares it plans to sell or their expected price.

March 14, 2012
A&P emerges from Chapter 11

Grocer A&P has emerged from bankruptcy as a privately held company.

MONTVALE, N.J. — Grocer A&P has emerged from bankruptcy as a privately held company.

As previously announced, Mount Kellett Capital Management, The Yucaipa Cos. and investment funds managed by Goldman Sachs Asset Management, have provided $490 million in debt and equity financing to sponsor A&P’s reorganization plan and complete its balance sheet restructuring. In addition, JP Morgan and Credit Suisse arranged a $645 million exit financing facility.

January 11, 2012
Amylin outlines diabetes strategy for 2012

A special focus on its diabetes franchise will define Amylin Pharmaceuticals' corporate strategy, the company's chief executive said at a recent conference sponsored by J.P. Morgan.

SAN DIEGO — A special focus on its diabetes franchise will define Amylin Pharmaceuticals' corporate strategy, the company's chief executive said at a recent conference sponsored by J.P. Morgan.

December 13, 2011
Report: Authorized generic versions of Lipitor capture 14.6% of script volume

Though they've been on the market for less than a month, the generic and authorized generic versions of Pfizer's cholesterol-lowering drug Lipitor have captured more than one-tenth of prescriptions, according to published reports.

NEW YORK — Though they've been on the market for less than a month, the generic and authorized generic versions of Pfizer's cholesterol-lowering drug Lipitor have captured more than one-tenth of prescriptions, according to published reports.

Citing an analysis of data from IMS Health by J.P. Morgan, The Wall Street Journal reported that Ranbaxy's generic atorvastatin calcium tablets and Watson Pharmaceuticals' authorized generic have claimed about 14.6% of prescription volume since their launch on Nov. 30.

January 14, 2011
'Time is right' for convenient care industry growth

Larry Merlo’s comments during the recent J.P. Morgan Healthcare Conference on the upswing in acute visits at MinuteClinic is important because it speaks to the fact that 2011 is the beginning of the second wave of clinic expansion.

WHAT IT MEANS AND WHY IT'S IMPORTANT — Larry Merlo’s comments during the recent J.P. Morgan Healthcare Conference on the upswing in acute visits at MinuteClinic is important because it speaks to the fact that 2011 is the beginning of the second wave of clinic expansion.

(THE NEWS: Acute visits climb as MinuteClinic preps for rapid growth. For the full story, click here)

January 12, 2011
Acute visits climb as MinuteClinic preps for rapid growth phase

CVS Caremark's retail-based clinic operator, MinuteClinic, is experiencing exponential gains in utilization and posted a 22% increase in acute visits during the past year, Larry Merlo, CVS Caremark president and COO, told investors Wednesday during the J.P. Morgan Healthcare Conference.

WOONSOCKET, R.I. — CVS Caremark's retail-based clinic operator, MinuteClinic, is experiencing exponential gains in utilization and posted a 22% increase in acute visits during the past year, Larry Merlo, CVS Caremark president and COO, told investors Wednesday during the J.P. Morgan Healthcare Conference.

January 12, 2011
Watson's revenue grows 25%

Though it plans to announce its fiscal year 2010 results next month, Watson Pharmaceuticals offered a peak at some preliminary numbers at the 29th annual J.P. Morgan Healthcare Conference Wednesday.

SAN FRANCISCO — Though it plans to announce its fiscal year 2010 results next month, Watson Pharmaceuticals offered a peak at some preliminary numbers at the 29th annual J.P. Morgan Healthcare Conference Wednesday.

Watson said that based on a review of results for last year, it expects to have earned revenues of more than $3.5 billion, a 25% increase over 2009.

September 12, 2010
Driving profitable sales on road back to black

Rite Aid’s road back to black still is long and pocked with challenges, but it’s...